Digital destination for sophisticated men & women. Live your best life with expert tips and news on health, food, sex, relationships, fashion and lifestyle.
Our content is fact checked by our senior editorial staff to reflect accuracy and ensure our readers get sound information and advice to make the smartest, healthiest choices. We adhere to structured guidelines for sourcing information and linking to other resources, including scientific studies and medical journals.
many have been waiting their whole lives for. Of course, when something seems too good to be true, it usually is. As Ozempic and other similar medications have risen in fame, some patients have noted that the medicine eventually stops working for weight loss, while fitness personality." But now, a new study is showing that it may be possible to quit Ozempic and still keep the weight off.Over the past year, people across the U.S. have gotten prescriptions for GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro, for weight loss. Amid the skyrocketing demand for these medications, employer-health plans have started tightening requirements or dropping coverage—and that has, a 41-year-old resident of Long Beach, California, told the newspaper that she had lost about 60 pounds after a year on her GLP-1 medication. But when she stopped taking it in the fall because her manufacturer savings card had expired, she regained 8 to 10 pounds in a month and a half. "I went into a panic, and during that time it was like my body was spiraling," she said, noting that she has since gotten insurance approval for Wegovy and has re-lost the weight."I had all this success. Now what if I just go backwards?"funded by Ozempic- and Wegovy-maker Novo Nordisk found that patients regained two-thirds of the weight they had lost on the drugs just one year after they stopped taking semaglutide injections.. "People who stop the medicine sometimes feel like their appetite comes roaring back—a double effect with hormonal changes due to weight loss." The study, which was led by experts at the University of Copenhagen in Denmark, involved a randomized controlled trial of 109 adults with obesity. The participants were randomly split into four groups. One of the groups was given liraglutide injections for a year. Another group was also given liraglutide injections for a year, but was assigned a moderate-to-vigorous monitored exercise plan for two hours a week during the trial. Neither of the last two groups were given weight-loss injections, but one underwent a supervised exercise plan similar to the second group, while the final group underwent no specific weight-loss plan. A year after the trial was concluded, researchers checked up on all of the groups to see how they were managing their weight on their own. They found that the group who had only taken liraglutide injections ended up regaining about two-thirds of their initial weight loss, which is in line with what Novo Nordisk's study found.an exercise plan during the trial fared the best overall. Many of the patients in this group were able to maintain a weight loss of at least 10 percent of their initial body weight one year after the trial was over, according to the study. "It is actually possible to stop taking the medication without large weight regain, if you follow a structured exercise regimen,"."Our study offers new hope, as we have shown that the majority of those who take weight loss medication and exercise regularly are able to maintain the beneficial effects a year after treatment termination."Best Life offers the most up-to-date information from top experts, new research, and health agencies, but our content is not meant to be a substitute for professional guidance. When it comes to the medication you're taking or any other health questions you have, always consult your healthcare provider directly.Kali Coleman is a Senior Editor at Best Life. Her primary focus is covering news, where she often keeps readers informed on the ongoing COVID-19 pandemic and up-to-date on the latest retail closures. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trialWalmart Shoppers May Be Eligible for $500Tish Cyrus "Stole" New Husband From DaughterWhy Dr. Terry Dubrow Quit Using Ozempic
Please follow us on Google to support usUnited States Latest News, United States Headlines
Similar News: You can also read news stories similar to this one that we have collected from other news sources.
Study Shows Collapse of Critical Atlantic Current System More Likely Than ThoughtThe Atlantic Meridional Overturning Circulation could be headed for a sudden 'cliff-like' shutdown.
Read more »
Texas makes top 10 list of most spoiled dogs in the US, study showsForbes Advisor recently ranked all 50 U.S. states and found that Texas ranks exceptionally high.
Read more »
Workers Shun Parental Benefits For Fear Of Being Judged, New Study ShowsI'm a freelance journalist covering business, economics and gender. I started my career at Reuters before working as a financial markets correspondent for The Wall Street Journal in London and then serving as business editor of The Independent. My book, WOMEN MONEY POWER, out in March 2024, is now available for pre-order.
Read more »
People in north Denver and Commerce City breathe in dirtier air, new CU Boulder study showsÓscar A. Contreras is a Murrow-nominated journalist who has been writing for the E.W. Scripps Company since January 2014.
Read more »
Small study shows a possible reason some long COVID patients experience 'brain fog'The study was conducted by researchers at Trinity College in Ireland.
Read more »
Caregivers Value Child Care Benefits Over 401(k), National Study ShowsChristine Michel Carter has written for Forbes since 2016 and has over 18 years of experience in editorial writing.
Read more »